Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

J. Hasford, M. Baccarani, V. Hoffmann, J. Guilhot, S. Saussele, G. Rosti, F. Guilhot, K. Porkka, G.J. Ossenkoppele, D. Lindoerfer, B. Simonsson, M. Pfirrmann, R. Hehlmann

Research output: Contribution to journalArticleAcademicpeer-review

358 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)686-692
Issue number3
Publication statusPublished - 2011

Cite this